Penta: Dôvera is not for sale

The investment group Penta has denied media reports that it intends to sell private health-insurer Dôvera to the government, Penta spokesman Martin Danko said on May 9.

The investment group Penta has denied media reports that it intends to sell private health-insurer Dôvera to the government, Penta spokesman Martin Danko said on May 9.

"We want to emphasise that Dôvera is not for sale, and we aren't holding any talks to that effect either with the state or with any private potential bidder," said Danko, as quoted by the TASR newswire. Danko stated that Penta has a long-term interest in the health-insurance sector and no sale is planned for the foreseeable future. Citing an unnamed source from within the investment group, the Hospodárske Noviny daily reported earlier on May 9 that the stance of Penta toward the sale of Dôvera had changed and that the government could buy the company for €400-450 million.

Source: TASR

Compiled by Zuzana Vilikovská from press reports
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.

Get daily Slovak news directly to your inbox

Top stories

News digest: Slovakia to spend three Advent weekends with testing. President wants it to be voluntary

Seven candidates for the general prosecutor post approved. Acting general prosecutor steps down.

Installation of Christmas tree in Trnava

Who was behind the sale of one of the biggest banks in Slovakia

The largest law firms were involved in several innovative projects, too.

UK nationals in Slovakia advised to take action as end of transition period nears

UK Nationals should check the British Embassy's "Living in Guide" for the most up-to-date information.

Illustrative stock photo

Three rounds of testing should take place before Christmas

The first round will be nationwide and should take place in two weeks.